Benefits in the later stages of MS (secondary progressive) are more modest and typically restricted to patients who are still experiencing relapses.
Uncedo olukhoyo kumanqanaba akamva esifo seMS (isifo esikhubaza nangakumbi) luphakathi yaye ludle ngokulungiselelwa kuphela izigulana ezinengxaki yokubuya kwesifo sizihlasele ngamandla.